\-\ Texto\\:\\ \ \(0\)\
\-\ in\\ film\\ 1\\ the\\ gallbladder\\ \\(gb\\)\\ wall\\ is\\ markedly\\ thickened\\ \\(1\\.7\\ cm\\)\\,\\ with\\ a\\ lamellated\\ or\\ striated\\ appearance\\.\\ \\ ascites\\ is\\ present\\.\\ \\ portal\\ venous\\ flow\\ \\(not\\ shown\\)\\ is\\ hepatopetal\\,\\ normal\\ in\\ direction\\.\\ \\ one\\ day\\ later\\ \\(film\\ 2\\)\\,\\ the\\ gb\\ wall\\ thickening\\ has\\ increased\\ to\\ the\\ point\\ \\(2\\.3\\ cm\\)\\ that\\ the\\ lumen\\ is\\ now\\ obliterated\\.\\ \\ portal\\ venous\\ flow\\ \\(film\\ 3\\)\\ has\\ reversed\\ and\\ is\\ now\\ hepatofugal\\.\ \(0\)\
\-\ gallbladder\\ wall\\ thickening\\,\\ secondary\\ to\\ portal\\ venous\\ hypertension\\ from\\ hepatic\\ venocclusive\\ disease\\ \\(after\\ bone\\ marrow\\ transplant\\)\ \(0\)\
\-\ this\\ is\\ a\\ 39\\-year\\-old\\ female\\ five\\ and\\ six\\ days\\ after\\ bone\\ marrow\\ transplant\\ for\\ aplastic\\ anemia\\.\\ \\ she\\ had\\ received\\ chemotherapy\\ and\\ total\\ lymphoid\\ radiation\\ prior\\ to\\ the\\ transplant\\.\\ \\ right\\ upper\\ quadrant\\ pain\\ and\\ tenderness\\ have\\ been\\ increasing\\ for\\ several\\ days\\.\\ \\ two\\ ultrasound\\ examinations\\ are\\ performed\\,\\ the\\ initial\\ one\\ at\\ 5\\ days\\ \\(film\\ 1\\)\\ and\\ the\\ follow\\-up\\ at\\ 6\\ days\\ \\(films\\ 2\\ and\\ 3\\)\\.\ \(0\)\
\-\ gb\\ wall\\ thickening\\ is\\ a\\ non\\-specific\\ finding\\ and\\ can\\ be\\ seen\\ with\\ both\\ intrinsic\\ and\\ extrinsic\\ disease\\ processes\\.\\ \\ acute\\ and\\ chronic\\ cholecystitis\\ are\\ the\\ most\\ common\\ intrinsic\\ causes\\ of\\ gb\\ wall\\ thickening\\ and\\ the\\ degree\\ of\\ thickening\\ can\\ be\\ marked\\.\\ \\ a\\ striated\\ appearance\\ of\\ the\\ wall\\ from\\ alternating\\ hyperechoic\\ and\\ anechoic\\ regions\\ has\\ been\\ shown\\ to\\ occur\\ more\\ frequently\\ in\\ acute\\ cholecystitis\\ but\\ can\\ also\\ be\\ seen\\ with\\ extrinsic\\ disease\\,\\ as\\ shown\\ in\\ this\\ case\\.\\ \\ even\\ though\\ stones\\ and\\ sludge\\ are\\ often\\ present\\,\\ especially\\ with\\ chronic\\ cholecystitis\\,\\ they\\ can\\ be\\ absent\\.\\ \\ pericholecystic\\ fluid\\ and\\ ascites\\ are\\ significantly\\ associated\\ with\\ perforation\\ when\\ acute\\ cholecystitis\\ is\\ present\\,\\ but\\ these\\ findings\\ may\\ also\\ occur\\ with\\ extrinsic\\ disease\\.\\ \\ when\\ bright\\ hyperechoic\\ intramural\\ foci\\ are\\ seen\\,\\ emphysematous\\ and\\ gangrenous\\ cholecystitis\\ should\\ be\\ considered\\,\\ but\\ again\\,\\ these\\ findings\\ are\\ non\\-specific\\.\\ \\ the\\ clinical\\ situation\\ is\\ often\\ very\\ helpful\\ in\\ determining\\ the\\ significance\\ of\\ these\\ findings\\.\\ \\ other\\ intrinsic\\ causes\\ of\\ gb\\ wall\\ thickening\\ include\\ adenomyomatosis\\ and\\ both\\ primary\\ and\\ metastatic\\ malignancy\\.\\ \\ gb\\ wall\\ thickening\\ can\\ be\\ diffuse\\,\\ focal\\,\\ or\\ even\\ circumferential\\ with\\ adenomyomatosis\\,\\ whereas\\ malignancy\\ is\\ usually\\ focal\\.\\ \\ malignant\\ changes\\ can\\ extend\\ intraluminally\\ or\\ extrinsically\\ as\\ well\\.\ \(0\)\
\-\ on\\ occasion\\,\\ if\\ the\\ patient\\ has\\ eaten\\ prior\\ to\\ the\\ ultrasound\\ study\\,\\ the\\ gb\\ may\\ be\\ normally\\ contracted\\ and\\ have\\ thick\\ walls\\.\\ \\ the\\ wall\\ usually\\ has\\ three\\ layers\\.\\ \\ \ \(0\)\
\-\ extrinsic\\ causes\\ of\\ gb\\ wall\\ thickening\\ are\\ numerous\\ and\\ include\\ aids\\,\\ hepatitis\\,\\ sepsis\\,\\ hypoalbuminemia\\,\\ congestive\\ heart\\ failure\\,\\ amyloidosis\\,\\ lymphatic\\ obstruction\\,\\ and\\ portal\\ hypertension\\ from\\ any\\ cause\\.\\ \\ ascites\\ has\\ been\\ associated\\ with\\ gb\\ wall\\ thickening\\.\\ \\ while\\ this\\ may\\ be\\ technical\\,\\ related\\ to\\ beam\\ spreading\\ artifact\\,\\ it\\ is\\ more\\ commonly\\ associated\\ with\\ hypoalbuminemia\\ and\\/or\\ portal\\ hypertension\\.\ \(0\)\
\-\ gb\\ wall\\ thickening\\ in\\ aids\\ has\\ been\\ associated\\ with\\ cytomegalic\\ virus\\ \\(cmv\\)\\,\\ cryptosporidium\\,\\ and\\ mycobacterium\\ infections\\.\\ \\ intrinsic\\ inflammatory\\ cell\\ infiltrate\\ has\\ been\\ documented\\,\\ but\\ many\\ cases\\ are\\ likely\\ to\\ be\\ secondary\\ to\\ primary\\ liver\\ involvement\\,\\ cholangitis\\,\\ or\\ more\\ diffuse\\ abdominal\\ infection\\.\ \(0\)\
\-\ hypoalbuminemia\\ has\\ been\\ well\\ documented\\ as\\ a\\ cause\\ of\\ gb\\ wall\\ thickening\\,\\ but\\ values\\ \\<2\\.5\\ g\\/dl\\ are\\ usually\\ necessary\\.\\ \\ malignant\\ ascites\\ has\\ not\\ been\\ associated\\ with\\ gb\\ wall\\ thickening\\,\\ except\\ when\\ the\\ albumin\\ level\\ is\\ low\\.\ \(0\)\
\-\ portal\\ hypertension\\ with\\ or\\ without\\ hypoalbuminemia\\ is\\ commonly\\ the\\ cause\\ of\\ gb\\ wall\\ thickening\\ most\\ often\\ associated\\ with\\ cirrhosis\\.\\ \\ the\\ findings\\ in\\ this\\ patient\\ are\\ of\\ acute\\ and\\ fulminant\\ portal\\ hypertension\\ from\\ hepatic\\ venocclusive\\ disease\\.\\ \\ the\\ portal\\ hypertension\\ develops\\ because\\ of\\ occlusion\\ of\\ the\\ venous\\ outflow\\ at\\ the\\ level\\ of\\ the\\ terminal\\ hepatic\\ venules\\ and\\ sublobular\\ veins\\.\\ \\ since\\ the\\ major\\ hepatic\\ veins\\ are\\ not\\ involved\\,\\ this\\ distinguishes\\ this\\ entity\\ from\\ the\\ classic\\ budd\\-chiari\\ syndrome\\,\\ even\\ though\\ both\\ may\\ cause\\ acute\\ portal\\ hypertension\\.\\ \\ it\\ is\\ believed\\ the\\ chemotherapy\\ and\\ radiation\\ directly\\ damage\\ the\\ venules\\ as\\ well\\ as\\ the\\ hepatocytes\\.\\ \\ further\\ damage\\ to\\ the\\ hepatocytes\\ occurs\\ from\\ the\\ congestion\\ and\\ hypoxia\\.\\ \\ graft\\-versus\\-host\\ disease\\ may\\ also\\ cause\\ portal\\ hypertension\\ in\\ bone\\ marrow\\ transplant\\ patients\\,\\ but\\ the\\ development\\ is\\ much\\ more\\ chronic\\ and\\ occurs\\ well\\ after\\ the\\ onset\\ of\\ disease\\.\ \(0\)\
\-\ marked\\ gb\\ wall\\ thickening\\ \\(\\>1\\.0\\ cm\\)\\ is\\ most\\ commonly\\ found\\ with\\ acute\\ cholecystitis\\,\\ hepatitis\\,\\ and\\ hepatic\\ venous\\ occlusion\\.\\ \\ the\\ striated\\ appearance\\ in\\ the\\ gb\\ wall\\ may\\ be\\ related\\ pathologically\\ to\\ hemorrhagic\\ edema\\.\\ \\ as\\ mentioned\\ previously\\,\\ this\\ finding\\ has\\ also\\ been\\ significantly\\ associated\\ with\\ acute\\ cholecystitis\\.\\ \\ the\\ clinical\\ setting\\ and\\ correlation\\ with\\ other\\ findings\\ should\\ help\\ determine\\ the\\ value\\ of\\ this\\ finding\\ for\\ a\\ given\\ patient\\.\\ \\ as\\ much\\ of\\ this\\ discussion\\ has\\ focused\\ on\\ hepatic\\ venocclusive\\ disease\\,\\ it\\ should\\ be\\ emphasized\\ that\\ hepatic\\ venocclusive\\ disease\\ is\\ rare\\ except\\ in\\ a\\ small\\ subset\\ of\\ patients\\.\\ \\ acute\\ cholecystitis\\,\\ however\\,\\ is\\ common\\.\ \(0\)\
\-\ to\\ determine\\ the\\ direction\\ of\\ flow\\ with\\ duplex\\ doppler\\,\\ the\\ angle\\ of\\ the\\ transducer\\,\\ the\\ angle\\ of\\ the\\ vessel\\ being\\ sampled\\,\\ and\\ the\\ relationship\\ of\\ the\\ spectral\\ tracing\\ to\\ the\\ baseline\\ are\\ the\\ key\\ considerations\\.\\ \\ flow\\ in\\ the\\ vessel\\ toward\\ the\\ transducer\\ registers\\ the\\ spectral\\ tracing\\ above\\ the\\ baseline\\,\\ whereas\\ flow\\ away\\ from\\ the\\ transducer\\ registers\\ below\\ the\\ baseline\\ \\(unless\\ manually\\ inverted\\)\\.\\ \\ in\\ this\\ patient\\,\\ the\\ spectral\\ tracing\\ from\\ the\\ portal\\ vein\\ is\\ below\\ the\\ baseline\\ on\\ day\\ 6\\ \\(film\\ 3\\)\\.\\ \\ the\\ transducer\\ angles\\ from\\ the\\ patient\\'s\\ right\\ to\\ left\\,\\ and\\ the\\ spectral\\ tracing\\ registers\\ below\\ the\\ baseline\\,\\ indicating\\ flow\\ away\\ from\\ the\\ transducer\\,\\ right\\ to\\ left\\,\\ or\\ abnormal\\ hepatofugal\\ flow\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ gb\\:\\ 0\\.100275361737002\ \(0\)\
\-\ portal\\:\\ 0\\.051539930640345906\ \(0\)\
\-\ wall\\:\\ 0\\.043830942754227796\ \(0\)\
\-\ thickening\\:\\ 0\\.04224244164136138\ \(0\)\
\-\ cholecystitis\\:\\ 0\\.037823769207920355\ \(0\)\
\-\ venocclusive\\:\\ 0\\.03673132676652707\ \(0\)\
\-\ tracing\\:\\ 0\\.03673132676652707\ \(0\)\
\-\ transducer\\:\\ 0\\.035083733761909694\ \(0\)\
\-\ hypoalbuminemia\\:\\ 0\\.030955100261860866\ \(0\)\
\-\ spectral\\:\\ 0\\.030955100261860866\ \(0\)\
\-\ hypertension\\:\\ 0\\.028073175435834898\ \(0\)\
\-\ registers\\:\\ 0\\.027548495074895308\ \(0\)\
\-\ baseline\\:\\ 0\\.02632457452225487\ \(0\)\
\-\ hepatic\\:\\ 0\\.026020271315252173\ \(0\)\
\-\ intrinsic\\:\\ 0\\.02573525455979683\ \(0\)\
\-\ extrinsic\\:\\ 0\\.021917376510321183\ \(0\)\
\-\ flow\\:\\ 0\\.020592059518760013\ \(0\)\
\-\ ascites\\:\\ 0\\.020431230910576467\ \(0\)\
\-\ has\\:\\ 0\\.020058749631178475\ \(0\)\
\-\ transplant\\:\\ 0\\.019671557757268324\ \(0\)\
\-\ striated\\:\\ 0\\.019533028332828006\ \(0\)\
\-\ been\\:\\ 0\\.019373290745533258\ \(0\)\
\-\ acute\\:\\ 0\\.017582327742554128\ \(0\)\
\-\ film\\:\\ 0\\.01709442153770301\ \(0\)\
\-\ hepatofugal\\:\\ 0\\.016921606757096985\ \(0\)\
\-\ venules\\:\\ 0\\.016921606757096985\ \(0\)\
\-\ venous\\:\\ 0\\.016155133429464213\ \(0\)\
\-\ hepatocytes\\:\\ 0\\.015477550130930433\ \(0\)\
\-\ be\\:\\ 0\\.015099295788315854\ \(0\)\
\-\ cause\\:\\ 0\\.01505865951329149\ \(0\)\
\-\ associated\\:\\ 0\\.01470337284724366\ \(0\)\
\-\ are\\:\\ 0\\.014560923406620022\ \(0\)\
\-\ \\,\\:\\ 0\\.014381472230605891\ \(0\)\
\-\ from\\:\\ 0\\.013192038678689712\ \(0\)\
\-\ disease\\:\\ 0\\.013094414448897225\ \(0\)\
\-\ adenomyomatosis\\:\\ 0\\.013022018888552003\ \(0\)\
\-\ can\\:\\ 0\\.012113889702931686\ \(0\)\
\-\ even\\:\\ 0\\.011890259780844507\ \(0\)\
\-\ marrow\\:\\ 0\\.011747726933181844\ \(0\)\
\-\ may\\:\\ 0\\.011714552305613274\ \(0\)\
\-\ below\\:\\ 0\\.011592415468955994\ \(0\)\
\-\ but\\:\\ 0\\.011390645631459612\ \(0\)\
\-\ aids\\:\\ 0\\.011145380252430774\ \(0\)\
\-\ is\\:\\ 0\\.011128671655531028\ \(0\)\
\-\ direction\\:\\ 0\\.01108127263020837\ \(0\)\
\-\ days\\:\\ 0\\.01091280956738324\ \(0\)\
\-\ shown\\:\\ 0\\.010707645919218743\ \(0\)\
\-\ documented\\:\\ 0\\.010680497853859503\ \(0\)\
\-\ whereas\\:\\ 0\\.01057885167850652\ \(0\)\
\-\ causes\\:\\ 0\\.010395564680655662\ \(0\)\
\-\ away\\:\\ 0\\.010344522546367583\ \(0\)\
\-\ non\\-specific\\:\\ 0\\.010300661277205433\ \(0\)\
\-\ hepatitis\\:\\ 0\\.010215615455288233\ \(0\)\
\-\ commonly\\:\\ 0\\.01007666076079888\ \(0\)\
\-\ this\\:\\ 0\\.010011845972022218\ \(0\)\
\-\ \\(\\:\\ 0\\.009781981709552278\ \(0\)\
\-\ \\)\\:\\ 0\\.009662489580701006\ \(0\)\
\-\ damage\\:\\ 0\\.00951463162899404\ \(0\)\
\-\ findings\\:\\ 0\\.009473109040572705\ \(0\)\
\-\ as\\:\\ 0\\.009425044313811349\ \(0\)\
\-\ extrinsically\\:\\ 0\\.009182831691631768\ \(0\)\
\-\ cytomegalic\\:\\ 0\\.009182831691631768\ \(0\)\
\-\ cryptosporidium\\:\\ 0\\.009182831691631768\ \(0\)\
\-\ sublobular\\:\\ 0\\.009182831691631768\ \(0\)\
\-\ graft\\-versus\\-host\\:\\ 0\\.009182831691631768\ \(0\)\
\-\ significantly\\:\\ 0\\.009110139932242045\ \(0\)\
\-\ except\\:\\ 0\\.009014337612988248\ \(0\)\
\-\ determine\\:\\ 0\\.009014337612988248\ \(0\)\
\-\ more\\:\\ 0\\.008904901288800693\ \(0\)\
\-\ hyperechoic\\:\\ 0\\.00890046592020103\ \(0\)\
\-\ occlusion\\:\\ 0\\.008878419859095744\ \(0\)\
\-\ finding\\:\\ 0\\.008606442203245255\ \(0\)\
\-\ gallbladder\\:\\ 0\\.00855414213052951\ \(0\)\
\-\ often\\:\\ 0\\.008520229839123913\ \(0\)\
\-\ veins\\:\\ 0\\.008516938760946162\ \(0\)\
\-\ should\\:\\ 0\\.0085131516934025\ \(0\)\
\-\ the\\:\\ 0\\.008496570622410335\ \(0\)\
\-\ vessel\\:\\ 0\\.0084803881158401\ \(0\)\
\-\ aplastic\\:\\ 0\\.008460803378548492\ \(0\)\
\-\ angle\\:\\ 0\\.00835728620673592\ \(0\)\
\-\ though\\:\\ 0\\.008257267000097669\ \(0\)\
\-\ much\\:\\ 0\\.008241054207510054\ \(0\)\
\-\ usually\\:\\ 0\\.008109150793333622\ \(0\)\
\-\ well\\:\\ 0\\.008054503970702712\ \(0\)\
\-\ hepatopetal\\:\\ 0\\.008038443890935821\ \(0\)\
\-\ eaten\\:\\ 0\\.008038443890935821\ \(0\)\
\-\ intraluminally\\:\\ 0\\.007738775065465216\ \(0\)\
\-\ fulminant\\:\\ 0\\.007738775065465216\ \(0\)\
\-\ distinguishes\\:\\ 0\\.007738775065465216\ \(0\)\
\-\ sampled\\:\\ 0\\.007738775065465216\ \(0\)\
\-\ when\\:\\ 0\\.007647910117550018\ \(0\)\
\-\ appearance\\:\\ 0\\.007637208052295755\ \(0\)\
\-\ chronic\\:\\ 0\\.007521842602834375\ \(0\)\
\-\ lamellated\\:\\ 0\\.007506333866179581\ \(0\)\
\-\ 39\\-year\\-old\\:\\ 0\\.007506333866179581\ \(0\)\
\-\ gangrenous\\:\\ 0\\.007506333866179581\ \(0\)\
\-\ emphasized\\:\\ 0\\.007506333866179581\ \(0\)\
\-\ related\\:\\ 0\\.007348440402649923\ \(0\)\
\-\ subset\\:\\ 0\\.007316415577852544\ \(0\)\
\-\ manually\\:\\ 0\\.007316415577852544\ \(0\)\
\-\ occurs\\:\\ 0\\.007306772347011027\ \(0\)\
\-\ cm\\:\\ 0\\.007162362868178081\ \(0\)\
\-\ also\\:\\ 0\\.007019248306958964\ \(0\)\
\-\ contracted\\:\\ 0\\.00701674675238194\ \(0\)\
\-\ spreading\\:\\ 0\\.00701674675238194\ \(0\)\
\-\ these\\:\\ 0\\.006949514662368251\ \(0\)\
\-\ marked\\:\\ 0\\.006947665626301056\ \(0\)\
\-\ malignancy\\:\\ 0\\.0068793534954198245\ \(0\)\
\-\ both\\:\\ 0\\.006819374970894129\ \(0\)\
\-\ reversed\\:\\ 0\\.006784305553096305\ \(0\)\
\-\ occasion\\:\\ 0\\.006784305553096305\ \(0\)\
\-\ mycobacterium\\:\\ 0\\.006784305553096305\ \(0\)\
\-\ budd\\-chiari\\:\\ 0\\.006784305553096305\ \(0\)\
\-\ obliterated\\:\\ 0\\.006685024115800133\ \(0\)\
\-\ occur\\:\\ 0\\.006679263809961538\ \(0\)\
\-\ bone\\:\\ 0\\.006635733379562094\ \(0\)\
\-\ inverted\\:\\ 0\\.006594387264769268\ \(0\)\
\-\ situation\\:\\ 0\\.006511009444276001\ \(0\)\
\-\ technical\\:\\ 0\\.006511009444276001\ \(0\)\
\-\ malignant\\:\\ 0\\.00643473057579021\ \(0\)\
\-\ 2\\.3\\:\\ 0\\.006433813639949207\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.006381137052376803\ \(0\)\
\-\ lymphoid\\:\\ 0\\.006294718439298663\ \(0\)\
\-\ or\\:\\ 0\\.006259517181023172\ \(0\)\
\-\ 3\\:\\ 0\\.006253048520957937\ \(0\)\
\-\ alternating\\:\\ 0\\.00623156779157321\ \(0\)\
\-\ to\\:\\ 0\\.006228076581460217\ \(0\)\
\-\ angles\\:\\ 0\\.006172027777156598\ \(0\)\
\-\ most\\:\\ 0\\.006165109817900238\ \(0\)\
\-\ now\\:\\ 0\\.006085657478545099\ \(0\)\
\-\ focused\\:\\ 0\\.006062277240013028\ \(0\)\
\-\ present\\:\\ 0\\.006031277356036503\ \(0\)\
\-\ beam\\:\\ 0\\.006011454152336536\ \(0\)\
\-\ g\\/dl\\:\\ 0\\.006011454152336536\ \(0\)\
\-\ it\\:\\ 0\\.0060026512016656776\ \(0\)\
\-\ lymphatic\\:\\ 0\\.005916691883372238\ \(0\)\
\-\ outflow\\:\\ 0\\.005916691883372238\ \(0\)\
\-\ pathologically\\:\\ 0\\.005916691883372238\ \(0\)\
\-\ duplex\\:\\ 0\\.005916691883372238\ \(0\)\
\-\ determining\\:\\ 0\\.0058723589516859916\ \(0\)\
\-\ cholangitis\\:\\ 0\\.0058723589516859916\ \(0\)\
\-\ radiation\\:\\ 0\\.005842190103254867\ \(0\)\
\-\ sludge\\:\\ 0\\.005829836040727393\ \(0\)\
\-\ virus\\:\\ 0\\.005829836040727393\ \(0\)\
\-\ albumin\\:\\ 0\\.0057496682895439265\ \(0\)\
\-\ emphysematous\\:\\ 0\\.0057117853268659315\ \(0\)\
\-\ cmv\\:\\ 0\\.0057117853268659315\ \(0\)\
\-\ intramural\\:\\ 0\\.005675231868729191\ \(0\)\
\-\ significance\\:\\ 0\\.005675231868729191\ \(0\)\
\-\ day\\:\\ 0\\.00565199964448527\ \(0\)\
\-\ pericholecystic\\:\\ 0\\.005639917752400357\ \(0\)\
\-\ hypoxia\\:\\ 0\\.005639917752400357\ \(0\)\
\-\ 1\\.7\\:\\ 0\\.005605761686959742\ \(0\)\
\-\ amyloidosis\\:\\ 0\\.005572690126215387\ \(0\)\
\-\ layers\\:\\ 0\\.005540636315104185\ \(0\)\
\-\ 1\\.0\\:\\ 0\\.005540636315104185\ \(0\)\
\-\ after\\:\\ 0\\.005525003758153758\ \(0\)\
\-\ congestive\\:\\ 0\\.005509539478489934\ \(0\)\
\-\ examinations\\:\\ 0\\.005479344127580296\ \(0\)\
\-\ anechoic\\:\\ 0\\.005479344127580296\ \(0\)\
\-\ sepsis\\:\\ 0\\.005479344127580296\ \(0\)\
\-\ clinical\\:\\ 0\\.005477728750137509\ \(0\)\
\-\ entity\\:\\ 0\\.005449999464073321\ \(0\)\
\-\ and\\:\\ 0\\.005437772048160766\ \(0\)\
\-\ circumferential\\:\\ 0\\.005393679441916784\ \(0\)\
\-\ develops\\:\\ 0\\.005393679441916784\ \(0\)\
\-\ diffuse\\:\\ 0\\.005389598792448573\ \(0\)\
\-\ believed\\:\\ 0\\.005340248926929751\ \(0\)\
\-\ 6\\:\\ 0\\.005316917002864322\ \(0\)\
\-\ mentioned\\:\\ 0\\.005314527455481448\ \(0\)\
\-\ infiltrate\\:\\ 0\\.00528942583925326\ \(0\)\
\-\ relationship\\:\\ 0\\.00528942583925326\ \(0\)\
\-\ ultrasound\\:\\ 0\\.005281505385429798\ \(0\)\
\-\ seen\\:\\ 0\\.005276961297086533\ \(0\)\
\-\ primary\\:\\ 0\\.005273717214366034\ \(0\)\
\-\ in\\:\\ 0\\.005267465376753187\ \(0\)\
\-\ cirrhosis\\:\\ 0\\.00524096748963358\ \(0\)\
\-\ key\\:\\ 0\\.00524096748963358\ \(0\)\
\-\ level\\:\\ 0\\.0051310188075977745\ \(0\)\
\-\ considerations\\:\\ 0\\.005128852214433199\ \(0\)\
\-\ terminal\\:\\ 0\\.005107807727644117\ \(0\)\
\-\ focal\\:\\ 0\\.005084361675288337\ \(0\)\
\-\ toward\\:\\ 0\\.005066952818109448\ \(0\)\
\-\ value\\:\\ 0\\.005047110948348309\ \(0\)\
\-\ include\\:\\ 0\\.004994069766729764\ \(0\)\
\-\ secondary\\:\\ 0\\.004977145763560015\ \(0\)\
\-\ correlation\\:\\ 0\\.004900671416451236\ \(0\)\
\-\ directly\\:\\ 0\\.004883733373876465\ \(0\)\
\-\ congestion\\:\\ 0\\.00485066181313211\ \(0\)\
\-\ one\\:\\ 0\\.0048244403818971755\ \(0\)\
\-\ processes\\:\\ 0\\.004818608002020909\ \(0\)\
\-\ 2\\.5\\:\\ 0\\.004818608002020909\ \(0\)\
\-\ unless\\:\\ 0\\.004818608002020909\ \(0\)\
\-\ artifact\\:\\ 0\\.004727971150990044\ \(0\)\
\-\ thick\\:\\ 0\\.004671651128833508\ \(0\)\
\-\ common\\:\\ 0\\.00465889002490916\ \(0\)\
\-\ patients\\:\\ 0\\.004607447082012554\ \(0\)\
\-\ helpful\\:\\ 0\\.004605280488847978\ \(0\)\
\-\ indicating\\:\\ 0\\.004592499142398172\ \(0\)\
\-\ stones\\:\\ 0\\.004579872725176979\ \(0\)\
\-\ perforation\\:\\ 0\\.004579872725176979\ \(0\)\
\-\ prior\\:\\ 0\\.00457106827542159\ \(0\)\
\-\ walls\\:\\ 0\\.004542886591367698\ \(0\)\
\-\ setting\\:\\ 0\\.00449552995170441\ \(0\)\
\-\ patient\\:\\ 0\\.004461416306856187\ \(0\)\
\-\ extend\\:\\ 0\\.0044613738862637935\ \(0\)\
\-\ bright\\:\\ 0\\.004450232960100515\ \(0\)\
\-\ values\\:\\ 0\\.004450232960100515\ \(0\)\
\-\ five\\:\\ 0\\.004439209929547872\ \(0\)\
\-\ help\\:\\ 0\\.004439209929547872\ \(0\)\
\-\ anemia\\:\\ 0\\.00442830232551944\ \(0\)\
\-\ normally\\:\\ 0\\.00438577941456084\ \(0\)\
\-\ six\\:\\ 0\\.00437541448658879\ \(0\)\
\-\ doppler\\:\\ 0\\.004305611663377373\ \(0\)\
\-\ lumen\\:\\ 0\\.004286497977264669\ \(0\)\
\-\ again\\:\\ 0\\.004277071065264755\ \(0\)\
\-\ 1\\:\\ 0\\.004236096599916056\ \(0\)\
\-\ infections\\:\\ 0\\.0042311752425626395\ \(0\)\
\-\ markedly\\:\\ 0\\.0042133685411467016\ \(0\)\
\-\ degree\\:\\ 0\\.0041701396547855\ \(0\)\
\-\ discussion\\:\\ 0\\.0041701396547855\ \(0\)\
\-\ major\\:\\ 0\\.004161705060793189\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.004153338215275205\ \(0\)\
\-\ received\\:\\ 0\\.0041368034765707365\ \(0\)\
\-\ other\\:\\ 0\\.0041034136431301015\ \(0\)\
\-\ regions\\:\\ 0\\.004073170464091738\ \(0\)\
\-\ thickened\\:\\ 0\\.003991574794018919\ \(0\)\
\-\ numerous\\:\\ 0\\.003991574794018919\ \(0\)\
\-\ necessary\\:\\ 0\\.003942792190181315\ \(0\)\
\-\ point\\:\\ 0\\.0038897021447729533\ \(0\)\
\-\ development\\:\\ 0\\.003876841899124725\ \(0\)\
\-\ not\\:\\ 0\\.0038588083491935482\ \(0\)\
\-\ frequently\\:\\ 0\\.0038578444120937034\ \(0\)\
\-\ absent\\:\\ 0\\.0038578444120937034\ \(0\)\
\-\ have\\:\\ 0\\.0038550793299272743\ \(0\)\
\-\ 2\\:\\ 0\\.003833551034396971\ \(0\)\
\-\ total\\:\\ 0\\.003833041653037746\ \(0\)\
\-\ foci\\:\\ 0\\.003820858278284422\ \(0\)\
\-\ and\\/or\\:\\ 0\\.00376199139259344\ \(0\)\
\-\ previously\\:\\ 0\\.0037393455731805176\ \(0\)\
\-\ involved\\:\\ 0\\.0037337602157415744\ \(0\)\
\-\ films\\:\\ 0\\.0036742202013249617\ \(0\)\
\-\ especially\\:\\ 0\\.003663751101477564\ \(0\)\
\-\ many\\:\\ 0\\.0036585557457368984\ \(0\)\
\-\ increasing\\:\\ 0\\.0036482421301299067\ \(0\)\
\-\ at\\:\\ 0\\.0036180098525988532\ \(0\)\
\-\ considered\\:\\ 0\\.0035932733426506736\ \(0\)\
\-\ failure\\:\\ 0\\.003486935711282674\ \(0\)\
\-\ rare\\:\\ 0\\.0034566147902846834\ \(0\)\
\-\ \\<\\:\\ 0\\.0034354849244810316\ \(0\)\
\-\ classic\\:\\ 0\\.003410682165425075\ \(0\)\
\-\ since\\:\\ 0\\.0032695464809356423\ \(0\)\
\-\ involvement\\:\\ 0\\.0032624361006539752\ \(0\)\
\-\ above\\:\\ 0\\.0032624361006539752\ \(0\)\
\-\ very\\:\\ 0\\.0032310266858928426\ \(0\)\
\-\ vein\\:\\ 0\\.0032207638770980385\ \(0\)\
\-\ later\\:\\ 0\\.0032139777510342958\ \(0\)\
\-\ they\\:\\ 0\\.003207235548424277\ \(0\)\
\-\ obstruction\\:\\ 0\\.0031389583839473286\ \(0\)\
\-\ quadrant\\:\\ 0\\.003132683264568807\ \(0\)\
\-\ because\\:\\ 0\\.0031140815797771333\ \(0\)\
\-\ being\\:\\ 0\\.003101862475833915\ \(0\)\
\-\ heart\\:\\ 0\\.0030927913009466397\ \(0\)\
\-\ inflammatory\\:\\ 0\\.0030867874418666914\ \(0\)\
\-\ that\\:\\ 0\\.0030749598511642154\ \(0\)\
\-\ liver\\:\\ 0\\.003068980740450754\ \(0\)\
\-\ given\\:\\ 0\\.003051473325537857\ \(0\)\
\-\ three\\:\\ 0\\.003000650237861365\ \(0\)\
\-\ cases\\:\\ 0\\.0029654279833136797\ \(0\)\
\-\ \\>\\:\\ 0\\.002957466161113088\ \(0\)\
\-\ initial\\:\\ 0\\.0029495647325826126\ \(0\)\
\-\ study\\:\\ 0\\.0029287826633957906\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.002895871866085148\ \(0\)\
\-\ a\\:\\ 0\\.002891873554927301\ \(0\)\
\-\ several\\:\\ 0\\.0028615550372108204\ \(0\)\
\-\ further\\:\\ 0\\.0028306709810419356\ \(0\)\
\-\ right\\:\\ 0\\.0028175990909700523\ \(0\)\
\-\ onset\\:\\ 0\\.0028098137770053645\ \(0\)\
\-\ found\\:\\ 0\\.0028052350150542834\ \(0\)\
\-\ any\\:\\ 0\\.0028029531594503058\ \(0\)\
\-\ while\\:\\ 0\\.0028006762915128262\ \(0\)\
\-\ tenderness\\:\\ 0\\.002707200336335035\ \(0\)\
\-\ 5\\:\\ 0\\.0026043337733793366\ \(0\)\
\-\ infection\\:\\ 0\\.002587517264659174\ \(0\)\
\-\ changes\\:\\ 0\\.0025510916419115215\ \(0\)\
\-\ two\\:\\ 0\\.0025493033725166726\ \(0\)\
\-\ syndrome\\:\\ 0\\.002545736017431918\ \(0\)\
\-\ abnormal\\:\\ 0\\.0025386377503280326\ \(0\)\
\-\ fluid\\:\\ 0\\.0025298324006290136\ \(0\)\
\-\ edema\\:\\ 0\\.0025176286348242614\ \(0\)\
\-\ likely\\:\\ 0\\.002510718714516309\ \(0\)\
\-\ she\\:\\ 0\\.0024987355640147626\ \(0\)\
\-\ performed\\:\\ 0\\.0024818524283617906\ \(0\)\
\-\ however\\:\\ 0\\.0024785083912469484\ \(0\)\
\-\ low\\:\\ 0\\.0024751750550691663\ \(0\)\
\-\ of\\:\\ 0\\.0024271625166247587\ \(0\)\
\-\ if\\:\\ 0\\.002415357743521495\ \(0\)\
\-\ cell\\:\\ 0\\.0024044174078973815\ \(0\)\
\-\ for\\:\\ 0\\.002278462964508485\ \(0\)\
\-\ on\\:\\ 0\\.002262159413641963\ \(0\)\
\-\ metastatic\\:\\ 0\\.002240738962100094\ \(0\)\
\-\ abdominal\\:\\ 0\\.00222491587304387\ \(0\)\
\-\ increased\\:\\ 0\\.002177588314374641\ \(0\)\
\-\ upper\\:\\ 0\\.002148000526425748\ \(0\)\
\-\ without\\:\\ 0\\.0020958470482897503\ \(0\)\
\-\ with\\:\\ 0\\.0020719489515917972\ \(0\)\
\-\ small\\:\\ 0\\.002050599254563665\ \(0\)\
\-\ left\\:\\ 0\\.0019918859776519057\ \(0\)\
\-\ \\'s\\:\\ 0\\.001962548560799005\ \(0\)\
\-\ case\\:\\ 0\\.001947400450903407\ \(0\)\
\-\ had\\:\\ 0\\.0019206768950424044\ \(0\)\
\-\ female\\:\\ 0\\.0018299586160914934\ \(0\)\
\-\ \\.\\:\\ 0\\.0016270620711283709\ \(0\)\
\-\ normal\\:\\ 0\\.001395429640207397\ \(0\)\
\-\ pain\\:\\ 0\\.0010870918411778486\ \(0\)\
